Safety of TG100-115 for Heart Attack Treated With Angioplasty
NCT00103350
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Myocardial Infarction
Interventions
DRUG:
TG100-115
Sponsor
TargeGen